Discovery Communications (NASDAQ: DISCA) recently posted a lackluster third quarter report which caused a dip in share price. A dip, which in my opinion, offers an excellent buying opportunity.
In the recent report, management projected that margins are likely to decrease as the company invests heavier in sports rights and higher quality content. Along with this announcement, EBITDA fell....More>>>
On Wednesday, stocks recovered following the worst day overall since October. The gains were led by the technology sector, which in many cases reversed following their worst day of the year on Tuesday.
However, despite the tech rebound, the blue chips lagged pulling the Dow Jones Industrial Average down less than 0.1%. Nike Inc (NYSE:NKE), a Dow component, fell 7.1%, pulled lower by a lackluster....More>>>
You must have braced yourself for a rate hike, if you have followed the tide. As widely expected, the Federal Reserve raised the benchmark interest rate by a quarter percentage point for the third time this year to a range of 1.25-1.5%. This clearly signals that the economy is in good health with inflation gradually crawling toward the desired 2% target and job market remaining robust. Together,....More>>>
The Facebook F8 developer conference kicked off last year on April 12, 2016, and the markets liked what they heard.
Last year, the Facebook stock price climbed 2.6% in one day thanks to CEO Mark Zuckerberg’s presentation of a 10-year road map for the company at the conference.
For the 2017 F8 developer conference, new plans and innovations could once again help shareholders....More>>>
Alnylam Pharmaceuticals (NASDAQ:ALNY) jumped as much as 14.5% today after announcing earnings after the bell yesterday. As a development-stage biotech, it wasn’t the revenue or the earnings that caused the spike, but the progression of Allnylam’s pipeline.
Nevertheless, here’s how the fourth quarter played out financially:
Alnylam Pharmaceuticals results: The raw....More>>>